Feeds

InterX sells Ideal Hardware for £18m

Abandons Pharmweb deal for 'leveraged investment'

  • alert
  • submit to reddit

Next gen security for virtualised datacentres

Timing is everything, as today's disposal of Ideal Hardware, a leading UK IT distie shows.

Owner InterX is flogging its once core business to Bell Microproducts for the princely sum of £18 million cash, £5 million of which is deferred until March 2001. And £2.7 million of that will end up straight in the maw of Inland Revenue, to settle the tax bill created by the departure of Ideal Hardware from the group.

InterX also retains the freeholds of Ideal's headquarters and distribution facilities in Chessington, Surrey, and has granted Bell the right to buy these for £16 million by October 2000.

The price extracted from Bell, a big US distie, for Ideal Hardware looks disappointingly low for a company that turns over more than £300 million and PBT of £6 million annually, and a company with net assets of £13 million.

But the sale has been a long-time coming - InterX has touted Ideal, the company from whence it sprang and the contributor for all its profits) in public since November last year. And sentiment has turned strongly against IT hardware distribution stocks.

A couple of years ago, InterX could have expected to have sold Ideal for £100 million, no trouble. Earlier this year, the company would have been satisfied with £60 million. Now it is walking away with just £30 million or so, net, in its pocket. It will spend the proceeds on developing InterX Technology, developer of Bladerunner, a wannabe competitor to Broadvision.

PharmWeb

InterX is not very good running content businesses, as displayed by its experience with the IT Network, recently bundled into ComputerWeekly.com, a Reed-Elsevier business in turn for a 25 per cent stake in the enlarged company.

Failure to ignite the world with the IT Network is probably a key reason for the company's decision to abandon takeover talks with Pharmweb, a pharmaceutical database, which it had announced in March it was buying for £20 million in cash and shares, as well as injecting £10 million in working capital.

It is stumping up £4 million instead for a 37.5 per cent in Diligenti, an B2B consolidator in the life-sciences sector. Crucially, it will migrate Diligenti's technology to the Bladerunner platform. But Pharmweb has not been left completely in the lurch - Diligenti is replacing Inter at negotiating table.

InterX is making available a convertible term loan facility of up to £16 million, presumably to help Diligenti complete a stack of acquisitions in the sector (three are mentioned in InterX's statement to the London Stock Exchange). Following the purchases, InterX's share in the firm is expected to fall to 15 per cent.

Scaling back

In March at the height of the market for tech stocks, InterX shares hit an incredible £38. For a brief
moment, it looked like the company could turn itself into a big-time new media publishing house, as well as a software developer. But timing is everything - now the company has scaled back to concentrate solely on its software business. This looks sensible.

Investments in other companies are now made mostly to secure new licences for Bladerunner. They are what InterX calls "leveraged" - in other words, it will sell stakes in Diligenti, Computerweekly.com and whatever comes along its way in future, when the time is ripe. ®

Related Stories

Philip Crawford to head up InterX
InterX folds IT publishing arm into ComputerWeekly.com

Secure remote control for conventional and virtual desktops

More from The Register

next story
6 Obvious Reasons Why Facebook Will Ban This Article (Thank God)
Clampdown on clickbait ... and El Reg is OK with this
No, thank you. I will not code for the Caliphate
Some assignments, even the Bongster decline must
Kaspersky backpedals on 'done nothing wrong, nothing to fear' blather
Founder (and internet passport fan) now says privacy is precious
TROLL SLAYER Google grabs $1.3 MEEELLION in patent counter-suit
Chocolate Factory hits back at firm for suing customers
Mozilla's 'Tiles' ads debut in new Firefox nightlies
You can try turning them off and on again
Sit tight, fanbois. Apple's '$400' wearable release slips into early 2015
Sources: time to put in plenty of clock-watching for' iWatch
Ex-IBM CEO John Akers dies at 79
An era disrupted by the advent of the PC
prev story

Whitepapers

5 things you didn’t know about cloud backup
IT departments are embracing cloud backup, but there’s a lot you need to know before choosing a service provider. Learn all the critical things you need to know.
Implementing global e-invoicing with guaranteed legal certainty
Explaining the role local tax compliance plays in successful supply chain management and e-business and how leading global brands are addressing this.
Backing up Big Data
Solving backup challenges and “protect everything from everywhere,” as we move into the era of big data management and the adoption of BYOD.
Consolidation: The Foundation for IT Business Transformation
In this whitepaper learn how effective consolidation of IT and business resources can enable multiple, meaningful business benefits.
High Performance for All
While HPC is not new, it has traditionally been seen as a specialist area – is it now geared up to meet more mainstream requirements?